A Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotypes 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5A

Clinical trial NCT03105349 · WITHDRAWN

Trial details

NCT number

NCT03105349

Sponsor

Fundacion SEIMC-GESIDA

Status

WITHDRAWN

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2017-07-01

Primary completion

2017-12-01

Enrollment

0

View on ClinicalTrials.gov